Read about brain tumor diagnosis stories and the latest in brain tumor research.
In June of 1990, while in the hospital after delivering her daughter Megan, Susie Hobbs was visited by her husband and their 4 year old son Matthew. While at the hospital Matthew told his dad that he wasn’t feeling well. The next day…
Matthew Hobbs, Medulloblastoma Read More »
(Seattle Times) – A dye derived from scorpion venom that lights up cancer cells so surgeons can see — and remove — deadly brain tumors will be tested for the first time in children, Seattle experts said Thursday. Officials with
Dye Based on Scorpion Venom Will Light Up Brain Cancer in Kids Read More »
DC News FOX 5 DC WTTG (myFOXDC.com) – A very tough little boy from Saline got a surprise. You may remember 4-year-old Chad Carr, or ‘Chad Tough’, who is fighting a rare brain cancer. He is the grandson of former
4-Year-Old With Cancer ‘Chad Tough’ Gets Surprise Backyard Beach Read More »
(National Institutes of Health) – Using brain tumor samples collected from children in the United States and Europe, an international team of scientists found that the drug panobinostat and similar gene regulating drugs may be effective at treating diffuse intrinsic
Study Points to Possible Treatment for Lethal Pediatric Brain Cancer Read More »
2 Years Old at Diagnosis During her second birthday party, Ellie began to feel ill. Of all the days in her short life to not feel well, it had to be on her second birthday. That night, Ellie threw up
Ellie Blaine, Pineoblastoma Read More »
Click Here to Donate to Joey’s Fund Today Joey’s Story Joey Keller was born on July 4, 2003 in Fort Wayne, Indiana. Little Joey entered the world around 9 pm, in the middle of a torrential downpour and huge booms
Eric Raabe, MD, PhD at Johns Hopkins University is a CureSearch Young Investigator studying the effect of a genetic mutation on the development of diffuse intrinsic pontine glioma (DIPG), a rare and difficult-to-treat brain tumor affecting children.
Researcher Seeks Answers to DIPG Read More »
“A new antibody therapy could dramatically improve outcomes for pediatric tumors.” What This Project Does Kathleen Sakamoto, MD, PhD Shelagh Galligan Professor in the School of MedicineStanford University A research team at Stanford University led by Drs. Kathleen Sakamoto and
Barriers to Treatment – Developing CD47 Antibody Therapy Read More »
In the last few years, researchers have learned much more about epigenetics. Epigenetics is the study of how and why certain genes get expressed. This knowledge has allowed scientists to better understand the mutations that cause cancer.
Overcoming Resistance in High Risk Medulloblastoma Read More »
